Details of the Drug

General Information of Drug (ID: DMXXSEA)

Drug Name
Cromolyn sodium
Synonyms Altoderm; Cromolyn sodium (topical, atopic dermatitis); Cromolyn sodium (topical, atopic dermatitis), Manhattan Pharmaceuticals
Indication
Disease Entry ICD 11 Status REF
Atopic dermatitis EA80 Approved [1]
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL
Chemical Identifiers
Formula
C23H14Na2O11
Canonical SMILES
C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)[O-])O)C(=O)C=C(O2)C(=O)[O-].[Na+].[Na+]
InChI
InChI=1S/C23H16O11.2Na/c24-11(9-31-14-3-1-5-16-20(14)12(25)7-18(33-16)22(27)28)10-32-15-4-2-6-17-21(15)13(26)8-19(34-17)23(29)30;;/h1-8,11,24H,9-10H2,(H,27,28)(H,29,30);;/q;2*+1/p-2
InChIKey
VLARUOGDXDTHEH-UHFFFAOYSA-L
Cross-matching ID
PubChem CID
27503
ChEBI ID
CHEMBL74
CAS Number
15826-37-6
TTD ID
D0G7IY
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug

References

1 ClinicalTrials.gov (NCT00745199) Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus. U.S. National Institutes of Health.